STOCK TITAN

Cohen & Steers Inc SEC Filings

CNS NYSE

Welcome to our dedicated page for Cohen & Steers SEC filings (Ticker: CNS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Cohen & Steers Inc. SEC filings reveal how a specialized asset manager navigates markets for real estate securities, infrastructure stocks, and preferred securities. The firm's quarterly 10-Q reports break down advisory fee revenue by product type and client channel, showing which investment strategies attract inflows and which face redemption pressure. For anyone analyzing the asset management industry, these disclosures illustrate how a focused manager competes against larger diversified firms.

The company's 10-K annual report provides detailed information on assets under management across institutional separate accounts, mutual funds, closed-end funds, and sub-advisory relationships. Footnotes explain how fee rates vary by strategy and client type, plus performance fee arrangements that can boost revenue during strong market periods. Segment disclosures reveal the contribution from U.S. versus international clients and how the business mix has evolved.

Form 4 insider transaction filings track buying and selling activity by Cohen & Steers executives and directors. In the asset management business, insider ownership signals whether leadership has personal capital aligned with outside shareholders. These filings appear promptly after any transaction, allowing investors to monitor insider sentiment in real time.

13F-HR filings disclose the firm's equity holdings, providing a window into Cohen & Steers' own investment positions. While the company primarily manages client assets, these quarterly holdings reports show where the firm's investment committees see value across real estate, infrastructure, and other sectors.

Our AI-powered analysis simplifies these filings by highlighting key fee rate trends, asset flow patterns, and changes to executive compensation structures found in proxy statements. Rather than reading through dozens of pages of regulatory text, get the essential insights that matter for understanding this real asset investment specialist.

Rhea-AI Summary

Cohen & Steers, Inc. reported an equity grant to one of its directors. On 01/02/2026, the director acquired 436 shares of common stock at a price of $0, increasing their holdings to 23,591 shares held directly.

The filing explains that these 436 shares reflect common stock underlying restricted stock units granted by the company. The restricted stock units were 100% vested on the grant date, and the related shares are scheduled to be delivered to the director on the third anniversary of the grant date. This is a routine insider compensation transaction rather than an open-market stock purchase.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Cohen & Steers, Inc. reported an equity award to one of its directors. On 01/02/2026, the director received 436 shares of common stock, recorded at a price of $0 because the shares relate to restricted stock units granted as compensation rather than a market purchase.

After this grant, the director beneficially owns 16,621 shares of Cohen & Steers common stock in direct form. The filing explains that the 436 shares represent common stock underlying restricted stock units that were 100% vested on the grant date, with the actual delivery of the related shares scheduled for the third anniversary of the grant date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Cohen & Steers, Inc. director and 10% owner Martin Cohen reported changes in his ownership of the company’s common stock. Following the reported activity, he beneficially owned 949,641 shares directly and 8,071,461 shares indirectly through the Martin Cohen 2018 Revocable Trust.

The filing shows an acquisition of 436 shares of common stock at a price of $0. These shares relate to restricted stock units granted by the company that were 100% vested on the grant date. The explanation notes that the related common shares will be delivered to the reporting person on the third anniversary of the grant date. Mr. Cohen disclaims beneficial ownership of the shares held by the trust except to the extent of his pecuniary interest.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Cohen & Steers, Inc. director reports stock award and trust transfer

A Cohen & Steers, Inc. director reported equity transactions in the company’s common stock. On 01/02/2026, the director acquired 436 shares of common stock at a price of $0, representing shares underlying restricted stock units that were fully vested on the grant date and scheduled to be delivered on the third anniversary of that grant. Following this, the director directly held 5,025 shares.

On 01/05/2026, the director transferred 419 shares of common stock to the Edmond Dennis Villani Revocable Trust and also reported that this trust held 30,678 shares after the transfer. After these transactions, the director directly held 4,606 shares and indirectly held additional shares through the revocable trust, for which the director and a family member serve as trustees.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Cohen & Steers, Inc. reported an equity grant to one of its directors. On 01/02/2026, the director acquired 436 shares of Cohen & Steers common stock at a price of $0, bringing their total beneficial ownership to 2,003 shares held directly.

The 436 shares represent common stock underlying restricted stock units that were 100% vested on the grant date. The filing explains that the related shares will be delivered to the director on the third anniversary of the grant date, meaning the director has earned the award but will receive the actual shares in the future.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Cohen & Steers, Inc. director reports stock-based award in a recent insider transaction. On 01/02/2026, a director of Cohen & Steers, Inc. (CNS) acquired 436 shares of common stock at a price of $0, reflecting the settlement terms of a stock-based grant rather than an open-market purchase.

The filing explains that these shares represent common stock underlying restricted stock units granted by the company. The restricted stock units were 100% vested on the grant date, and the related shares will be delivered to the director on the third anniversary of the grant date. Following this transaction, the director beneficially owns 9,474 shares of Cohen & Steers common stock in direct ownership form.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Cohen & Steers, Inc. reported a routine insider equity grant for one of its directors. On 01/02/2026, the director acquired 436 shares of Cohen & Steers common stock at a price of $0 per share, increasing the director’s beneficial ownership to 1,738 shares held directly.

The filing explains that these 436 shares represent common stock underlying restricted stock units granted by the company. The restricted stock units were 100% vested on the grant date, and the underlying shares are scheduled to be delivered to the director on the third anniversary of the grant date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Cohen & Steers, Inc. (CNS)11/20/2025, the reporting person acquired 1,401 shares of common stock at a price of $0, reported as an acquisition of dividend equivalent restricted stock units tied to the company’s fourth quarter 2025 dividend and accruing on previously granted unvested restricted stock units from January 2022, 2023, 2024 and 2025.

Following this transaction, the reporting person directly beneficially owns 1,288,432 shares of common stock. In addition, 305,000 shares are held indirectly through a limited liability company owned by a family trust, for which the reporting person disclaims beneficial ownership except to the extent of any pecuniary interest.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Cohen & Steers, Inc. (CNS) executive vice president reported an automatic share-based accrual tied to company dividends. On 11/20/2025, the officer acquired 220 shares of common stock at a price of $0, reflecting dividend equivalent restricted stock units credited in connection with the issuer's fourth quarter 2025 dividend. These units accrued on unvested restricted stock units previously granted in June 2024 and January 2025. Following this transaction, the officer beneficially owned 23,123 shares of Cohen & Steers common stock, held directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Cohen & Steers, Inc. (CNS)11/20/2025, the officer acquired 227 shares of common stock at a price of $0. These shares are described as dividend equivalent restricted stock units that accrued on earlier unvested restricted stock unit grants from January 2022, January 2023, January 2024 and January 2025 in connection with the company’s fourth quarter 2025 dividend. After this transaction, the officer beneficially owns 528,903 shares of Cohen & Steers common stock, held directly. This filing reflects compensation-related accruals rather than an open-market purchase or sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

What is the current stock price of Cohen & Steers (CNS)?

The current stock price of Cohen & Steers (CNS) is $68.04 as of January 9, 2026.

What is the market cap of Cohen & Steers (CNS)?

The market cap of Cohen & Steers (CNS) is approximately 3.4B.
Cohen & Steers Inc

NYSE:CNS

CNS Rankings

CNS Stock Data

3.43B
27.29M
46.02%
60.33%
3.88%
Asset Management
Investment Advice
Link
United States
NEW YORK